Artemisone uptake in Plasmodium falciparum-infected erythrocytes

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 2, 2011, Pages 550-556

  Pooley, Sophie ^a   Fatih, Farrah A ^a   Krishna, Sanjeev ^a   Gerisch, Michael ^b   Haynes, Richard K ^c   Wong, Ho Ning ^c   Staines, Henry M ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b BAYER PHARMA AG   (Germany)

^c HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISONE C 14; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL EVALUATION; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DRUG BINDING; DRUG METABOLISM; DRUG TRANSPORT; DRUG UPTAKE; ERYTHROCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; ISOTOPE LABELING; MALARIA FALCIPARUM; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ANTIMALARIALS; ARTEMISININS; CARBON RADIOISOTOPES; ERYTHROCYTES; HUMANS; PLASMODIUM FALCIPARUM;

EID: 78751695811     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01216-10     Document Type: Article

References (29)

1. Akompong, T., J. VanWye, N. Ghori, and K. Haldar. 1999. Artemisinin and its derivatives are transported by a vacuolar-network of Plasmodium falciparum and their anti-malarial activities are additive with toxic sphingolipid analogues that block the network. Mol. Biochem. Parasitol. 101:71-79.
2. Angus, B. J., K. Chotivanich, R. Udomsangpetch, and N. J. White. 1997. In vivo removal of malaria parasites from red blood cells without their destruction in acute falciparum malaria. Blood 90:2037-2040.
3. Chavchich, M., et al. 2010. Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum. Antimicrob. Agents Chemother. 54:2455-2464.
4. II: significance for mode of action and implications for therapy of cerebral malaria. ChemMedChem 4:2045-2053.
5. Desjardins, R. E., C. J. Canfield, J. D. Haynes, and J. D. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
6. Dondorp, A. M., et al. 2009. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361:455-467.
7. Dunay, I. R., W. C. Chan, R. K. Haynes, and L. D. Sibley. 2009. Artemisone and artemiside control acute and reactivated toxoplasmosis in a murine model. Antimicrob. Agents Chemother. 53:4450-4456.
8. Goo, Y. K., et al. 2010. Artesunate, a potential drug for treatment of Babesia infection. Parasitol. Int. 59:481-486.
9. 3H]dihydroartemisinine by erythrocytes infected with Plasmodium falciparum in vitro. Trans. R. Soc. Trop. Med. Hyg. 78:265-270.
10. 2+-mediated decomposition, PfATP6 binding, and antimalarial activities of artemisone and other artemisinins: the unlikelihood of C-centered radicals as bioactive intermediates. ChemMedChem 2:1480-1497.
11. Haynes, R. K., et al. 2010. Facile oxidation of leucomethylene blue and dihydroflavins by artemisinins: relationship with flavoenzyme function and antimalarial mechanism of action. ChemMedChem 5:1282-1299.
12. Haynes, R. K., et al. 2006. Artemisone - a highly active antimalarial drug of the artemisinin class. Angew. Chem. Int. Ed. Engl. 45:2082-2088.
13. Kamchonwongpaisan, S., G. Chandra-ngam, M. A. Avery, and Y. Yuthavong. 1994. Resistance to artemisinin of malaria parasites (Plasmodium falciparum) infecting α-thalassemic erythrocytes in vitro. Competition in drug accumulation with uninfected erythrocytes. J. Clin. Invest. 93:467-473.
14. Krishna, S., L. Bustamante, R. K. Haynes, and H. M. Staines. 2008. Artemisinins: their growing importance in medicine. Trends Pharmacol. Sci. 29:520-527.
15. Krishna, S., S. Pulcini, F. A. Fatih, and H. M. Staines. 2010. Artemisinins and the biological basis for the PfATP6/SERCA hypothesis. Trends Parasitol. 26:517-523.
16. Matsuu, A., M. Yamasaki, X. Xuan, H. Ikadai, and Y. Hikasa. 2008. In vitro evaluation of the growth inhibitory activities of 15 drugs against Babesia gibsoni (Aomori strain). Vet. Parasitol. 157:1-8.
17. Meshnick, S. R., A. Thomas, A. Ranz, C. M. Xu, and H. Z. Pan. 1991. Artemisinin (qinghaosu): the role of intracellular hemin in its mechanism of antimalarial action. Mol. Biochem. Parasitol. 49:181-189.
18. Nagelschmitz, J., et al. 2008. First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone. Antimicrob. Agents Chemother. 52:3085-3091.
19. Noedl, H., et al. 2008. Evidence of artemisinin-resistant malaria in western Cambodia. N. Engl. J. Med. 359:2619-2620.
20. Roberts, D. J., et al. 1992. Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature 357:689-692.
21. Schmuck, G., M. Temerowski, R. K. Haynes, and B. Fugmann. 2003. Identification of non-neurotoxic artemisinin derivatives in vivo and in vitro. Recent Res. Dev. Antimicrob. Agents Chemother. 3:35-47.
22. + transport in Plasmodium falciparum-infected red cells. J. Membr. Biol. 172:13-24.
23. ter Kuile, F., N. J. White, P. Holloway, G. Pasvol, and S. Krishna. 1993. Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. Exp. Parasitol. 76:85-95.
24. Vattanaviboon, P., N. Siritanaratkul, J. Ketpirune, P. Wilairat, and Y. Yuthavong. 2002. Membrane heme as a host factor in reducing effectiveness of dihydroartemisinin. Biochem. Pharmacol. 64:91-98.
25. Vyas, N., B. A. Avery, M. A. Avery, and C. M. Wyandt. 2002. Carrier-mediated partitioning of artemisinin into Plasmodium falciparum-infected erythrocytes. Antimicrob. Agents Chemother. 46:105-109.
26. Walker, D. J., et al. 2000. Mechanisms of artemisinin resistance in the rodent malaria pathogen Plasmodium yoelii. Antimicrob. Agents Chemother. 44:344-347.
27. Wang, J., et al. 2010. Artemisinin directly targets malarial mitochondria through its specific mitochondrial activation. PLoS One 5:e9582.
28. Witkowski, B., et al. 2010. Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism. Antimicrob. Agents Chemother. 54:1872-1877.
29. Yang, Y. Z., B. Little, and S. R. Meshnick. 1994. Alkylation of proteins by artemisinin. Effects of heme, pH, and drug structure. Biochem. Pharmacol. 48:569-573.